Boston's Clik Anchor spinal lead fixation device approved in the US
This article was originally published in Clinica
The Clik Anchor, a device developed by Boston Scientific to aid placement of its Precision Plus spinal cord stimulator, has gained US premarket approval (PMA). The Clik Anchor uses a locking system to fix the leads – the wires through which painkilling impulses pass – more quickly and consistently. It locks into place on the lead with a turn of an Allen key and provides tactile and audible confirmation that the lead is secured. The firm will launch the Clik Anchor immediately. The Precision Plus is indicated for the management of chronic intractable pain of the trunk and/or limbs. The leads themselves were approved in the US last year (www.clinica.co.uk, 2 August 2010)
You may also be interested in...
Dr Noam Emanuel is the founder and chief technology officer of Ness Ziona, Israel-based drug delivery firm PolyPid. The 15-strong firm, established in 2008, has developed an encapsulation technology which allows the precise targeting of drug release.
Mesoblast has received the all-clear from the US FDA to start a Phase III clinical trial for bone marrow regeneration in patients with blood cancers. The study will be conducted together with Mesoblast's strategic alliance partner, Cephalon, which will fund the trial.
Mesoblast has received the green light from the US FDA to begin a Phase II trial of its proprietary adult mesenchymal precursor cell (MPC) product for the treatment of degenerative disc disease, a major cause of chronic low back pain.